| Filed On | Filing |
|---|---|
| 03 Apr 2026 |
Form 4: Stockburger Aileen Ptucha, Director
Granted 10,000 Stock Option (Right to Buy) |
| 03 Apr 2026 |
Form 4: Madden Martin J., Director
Granted 10,000 Stock Option (Right to Buy) |
| 03 Apr 2026 |
Form 4: Wenderow Tal Baruch, Director
Granted 10,000 Stock Option (Right to Buy) |
| 03 Apr 2026 |
Form 4: Wilson David James, Director
Granted 10,000 Stock Option (Right to Buy) |
| 03 Apr 2026 |
Form 4: Burell Scott R, Director
Granted 10,000 Stock Option (Right to Buy) |
| 03 Apr 2026 |
Form 4: Laxminarain Prattipati, Director
Granted 10,000 Stock Option (Right to Buy) |
| 20 Feb 2026 |
Form 4: Gadot Harel, Director
Granted 480,000 Stock Option (Right to Buy) |
| 20 Feb 2026 |
Form 4: Diaz-Cartelle Juan, Chief Medical Officer
Granted 105,000 Stock Option (Right to Buy) |
| 20 Feb 2026 |
Form 4: Sharon Simon, General Manager, CTO
Granted 105,000 Stock Option (Right to Buy) |
| 20 Feb 2026 |
Form 4: Vaknin Rachel, Chief Financial Officer
Granted 105,000 Stock Option (Right to Buy) |
| 07 Feb 2025 |
Form 4: Vaknin Rachel, Chief Financial Officer
Granted 4,375 Stock Option (Right to Buy) · Granted 48,125 Stock Option (Right to Buy) |
| 07 Feb 2025 |
Form 4: Sharon Simon, General Manager, CTO
Granted 8,750 Stock Option (Right to Buy) · Granted 43,750 Stock Option (Right to Buy) |
| 07 Feb 2025 |
Form 4: Gadot Harel, Director
Granted 12,000 Stock Option (Right to Buy) · Granted 228,000 Stock Option (Right to Buy) |
| 07 Feb 2025 |
Form 4: Diaz-Cartelle Juan, Chief Medical Officer
Granted 10,500 Stock Option (Right to Buy) · Granted 42,000 Stock Option (Right to Buy) |
| 30 Jan 2025 |
Form 4: Madden Martin J., Director
Granted 10,000 Stock Option (Right to Buy) |
| 30 Jan 2025 |
Form 4: Burell Scott R, Director
Granted 10,000 Stock Option (Right to Buy) |
| 30 Jan 2025 |
Form 4: Wenderow Tal Baruch, Director
Granted 10,000 Stock Option (Right to Buy) |
| 30 Jan 2025 |
Form 4: Stockburger Aileen Ptucha, Director
Granted 10,000 Stock Option (Right to Buy) |
| 30 Jan 2025 |
Form 4: Wilson David James, Director
Granted 20,000 Stock Option (Right to Buy) |
| 30 Jan 2025 |
Form 4: Laxminarain Prattipati, Director
Granted 10,000 Stock Option (Right to Buy) |
Loading...